Jesper Høiland
Director/Board Member chez ALK-ABELLÓ A/S
Profil
Jesper Høiland's career history includes current positions as a Director at ALK-Abello A and as a Senior Vice President at Novo Nordisk North America, Inc. He previously served as the President, Chief Executive Officer, and Director at Radius Health, Inc. from 2017 to 2020.
He also held positions as an Independent Director at Concert Pharmaceuticals, Inc., a Director at LEO Pharma A, and a Director at Pharmaceutical Research & Manufacturers of America from 2014 to 2016.
From 2004 to 2012, he was the Senior Vice President of International Operations at Novo Nordisk A.
Mr. Høiland was the President of Novo Nordisk, Inc. from 2013 to 2017.
Additionally, he worked as a Management Consultant at Liseberg AB from 1985 to 1987 and as the General Manager at Novo Nordisk Pharmaceuticals Pty Ltd.
Mr. Høiland obtained a graduate degree from Copenhagen Business School in 1985.
His current job(s) include Director at ALK-Abello A and Senior Vice President at Novo Nordisk North America, Inc.
Postes actifs de Jesper Høiland
| Sociétés | Poste | Début |
|---|---|---|
| ALK-ABELLÓ A/S | Director/Board Member | - |
| Novo Nordisk North America, Inc. | Corporate Officer/Principal | 01/01/2013 |
Anciens postes connus de Jesper Høiland
| Sociétés | Poste | Fin |
|---|---|---|
| ASCENDIS PHARMA A/S | Corporate Officer/Principal | 23/05/2022 |
| RADIUS HEALTH, INC. | Chief Executive Officer | 28/04/2020 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | President | 01/03/2017 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Board Member | 01/01/2016 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/2012 |
Formation de Jesper Høiland
| Copenhagen Business School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| ALK-ABELLÓ A/S | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| Entreprise privées | 8 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
| Novo Nordisk North America, Inc. | |
| Liseberg AB | |
Novo Nordisk Pharmaceuticals Pty Ltd.
 Novo Nordisk Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharmaceuticals Pty Ltd. manufactures pharmaceuticals for diabetes care. The company is headquartered in Baulkham Hills, Australia. | Health Technology |
